Genzyme's Termeer: Worst Biotech CEO of '09
Genzyme CEO Henri Termeer is Adam Feuerstein's Worst Biotech CEO of the Year for 2009.
12:31PM 11/17/09
NEW YORK (TheStreet) -- Auxilium CEO Armando Anido tells TSC's Debra Borchardt of the future plans for its soon-to-be-launched drug Xiaflex for collagen based diseases.
09:00AM 11/16/09
Alcoa, Liz Claiborne, NCR, PepsiCo Big Movers
Alcoa, Liz Claiborne, NCR, PepsiCo, Marriott, Monster are among big market movers Thursday
04:55PM 10/08/09
Yum Brands, Monsanto, Family Dollar Big Movers
Yum Brands, Monsanto, Family Dollar, Costco, Google are among big market movers Wednesday
06:07PM 10/07/09
Repros Surges On Study Data For Hormone Treatment
Repros Therapeutics stock more than doubles on positive study results for Androxal
11:50AM 10/07/09
Early Movers: Pump Up the Volume
Several small-cap stocks were poised to move on above-average volume during Wednesday's session.
08:51AM 10/07/09
Oculus Insider to Sell Microcyn: BioBuzz
Oculus turns to a director and large shareholder for Microcyn marketing help.
01:35PM 09/29/09
FDA Sends More Bad News to Repros: BioBuzz
Proellex's future is in doubt after it received a letter from the FDA.
09:33AM 09/29/09
Repros To Try To License Stalled Drug Candidate
Repros to try to license stalled drug candidate Propellex after FDA requests more information
08:05AM 09/29/09
Biocryst Flu Drug Missing From CDC Guidelines: BioBuzz
Investors waiting for government to buy emergency stockpile of peramivir
02:27PM 09/08/09
Spectrum shares fall despite drug approval: BioBuzz
Uncertainty over Zevalin's relaunch likely weighing on stock price
11:18AM 09/08/09
Osiris Stem Cell Drug Fails: BioBuzz
Negative results announced from two phase III studies in graft-versus-host-disease
08:44AM 09/08/09
Cell Therapeutics Gets Standard Review: BioBuzz
FDA appeal denied, cancer drug pixantrone's approval decision date remains April 2010
06:59AM 09/08/09
Movers Roundup: Repros Therapeutics, Abercrombie
Movers roundup: Repros Therapeutics hits low on bankruptcy worries, Abercrombie & Fitch drops
02:19PM 08/17/09
Repros Plunges As Company Says May Face Bankruptcy
Repros Therapeutics says it is short of cash and hired bankruptcy law firm; stock sets new low
01:58PM 08/17/09



Connect with TheStreet